Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma ADR (NQ: ASND )

110.97 USD -7.33 (-6.19%)
Streaming Delayed Price Updated: 3:43 PM EST, Jan 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 229,390
Open 119.81
Bid (Size) 110.82 (1)
Ask (Size) 111.11 (3)
Prev. Close 118.29
Today's Range 110.71 - 126.75
52wk Range 109.36 - 178.71
Shares Outstanding 53,750,386
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval
TheEuropean Commission (EC) has granted marketing authorizationto Ascendis Pharma A/S's (NASDAQ: ASND) Lonapegsomatropin ... 
Tags General ASND Benzinga
From Benzinga
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH and TransCon™ CNP at the American Society for Bone & Mineral Research 2021 Annual Meeting
From GlobeNewswire News Releases

Performance

YTD
-18.26%
-18.26%
1 Month
-18.07%
-18.07%
3 Month
-23.47%
-23.47%
6 Month
-9.05%
-9.05%
1 Year
-29.89%
-29.89%

More News

Read More
Where Ascendis Pharma Stands With Analysts
Tags Market News BZI/AAR Benzinga
From Benzinga
Ascendis Pharma A/S Announces Share Repurchase Program
From GlobeNewswire News Releases
ASND Crosses Above Key Moving Average Level
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
Tags Market News News CADL
From Benzinga
Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks
Tags Market News News General
From Benzinga
10 Biggest Price Target Changes For Monday
Tags Price Target WRBY KRUS
From Benzinga
Analyst Ratings For Ascendis Pharma
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Ascendis Pharma Breaks Below 200-Day Moving Average - Notable for ASND
Tags Stocks
From Market News Video
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript
Tags ASND Recent Press Releases Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.